TESTA, LUCA
 Distribuzione geografica
Continente #
EU - Europa 3.691
NA - Nord America 3.409
AS - Asia 2.809
SA - Sud America 670
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 54
OC - Oceania 1
Totale 10.916
Nazione #
US - Stati Uniti d'America 3.147
RU - Federazione Russa 2.092
SG - Singapore 1.069
IT - Italia 1.004
CN - Cina 763
BR - Brasile 556
HK - Hong Kong 413
VN - Vietnam 242
FR - Francia 162
BD - Bangladesh 113
CA - Canada 106
DE - Germania 92
GB - Regno Unito 75
SE - Svezia 56
IN - India 51
MX - Messico 50
AT - Austria 48
NL - Olanda 35
FI - Finlandia 32
JM - Giamaica 31
AR - Argentina 28
IQ - Iraq 24
EC - Ecuador 22
JP - Giappone 22
ZA - Sudafrica 22
PL - Polonia 21
CR - Costa Rica 19
ES - Italia 18
ID - Indonesia 18
TR - Turchia 18
VE - Venezuela 17
NI - Nicaragua 15
CL - Cile 11
CO - Colombia 11
UA - Ucraina 11
PY - Paraguay 10
HN - Honduras 9
RO - Romania 9
LT - Lituania 8
PE - Perù 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
SA - Arabia Saudita 7
TN - Tunisia 7
MA - Marocco 6
MY - Malesia 6
NP - Nepal 6
PR - Porto Rico 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 4
BB - Barbados 4
GT - Guatemala 4
IL - Israele 4
JO - Giordania 4
MD - Moldavia 4
PH - Filippine 4
PK - Pakistan 4
AM - Armenia 3
BE - Belgio 3
CH - Svizzera 3
EE - Estonia 3
IE - Irlanda 3
KE - Kenya 3
OM - Oman 3
UY - Uruguay 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
IR - Iran 2
KZ - Kazakistan 2
PT - Portogallo 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
VC - Saint Vincent e Grenadine 2
ZM - Zambia 2
A1 - Anonimo 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GF - Guiana Francese 1
GR - Grecia 1
GY - Guiana 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
Totale 10.626
Città #
Singapore 521
Ashburn 519
San Jose 454
Moscow 449
Hong Kong 409
Dallas 399
Milan 287
Council Bluffs 213
Hefei 169
Lauterbourg 143
Phoenix 137
Shanghai 127
Beijing 115
Rome 73
Ho Chi Minh City 72
Santa Clara 64
New York 62
Los Angeles 61
Hanoi 60
Naples 48
Nuremberg 42
São Paulo 41
Turin 37
Miano 30
Orem 30
Bologna 29
Brooklyn 27
Montreal 25
Toronto 25
Boardman 24
Mexico City 24
Washington 24
Atlanta 23
North Bergen 23
Denver 22
Chicago 19
London 19
Warsaw 19
Kingston 18
Princeton 18
Vienna 18
Amsterdam 17
Belo Horizonte 17
Catania 16
Lawrence 16
Bari 15
Brescia 15
Da Nang 15
Helsinki 15
Managua 15
Munich 15
Assago 14
Manchester 14
San José 14
Seattle 14
Tokyo 14
Florence 13
Frankfurt am Main 13
Genoa 13
Johannesburg 13
Miami 13
Chennai 12
Omaha 12
Boston 11
Brasília 11
Buffalo 11
Charlotte 11
Poplar 11
Quito 11
Rio de Janeiro 11
Turku 11
Figino 10
Houston 10
Las Vegas 9
Palermo 9
San Francisco 9
Stockholm 9
Dhaka 8
Manaus 8
Mumbai 8
Padua 8
Philadelphia 8
Porto Alegre 8
Salvador 8
Tampa 8
Tashkent 8
Verona 8
Betim 7
Erbil 7
Guangzhou 7
Guayaquil 7
Milwaukee 7
Modena 7
Ribeirão Preto 7
Caracas 6
Changsha 6
Curitiba 6
Falkenstein 6
Fortaleza 6
Goiânia 6
Totale 5.543
Nome #
Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women with Preconception Immunity (CHILd Study) 246
Coronary Protection to Prevent Coronary Obstruction During TAVR 167
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 166
Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis 123
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 99
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 98
Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation. 97
Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study 97
Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis 96
Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction 92
Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR 91
Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves 90
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after TAVR: insights from the Recovery TAVR registry 89
Extra- Mitral Valve Cardiac Involvement in Patients With Primary Mitral Regurgitation Undergoing Transcatheter Edgeto- Edge Repair 87
Acute worsening in migraine symptoms following PFO closure: a matter of fact? 85
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 85
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death 84
Impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair 82
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis 82
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 82
A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique 82
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis 81
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System 80
[SICI-GISE Position paper on the use of the magnesium bioresorbable scaffold Magmaris in clinical practice] 80
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes 79
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 79
Prognostic Significance of Flail Mitral Leaflet in Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation 79
Comparison of Incidence and Predictors of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Using the CoreValve Versus the Edwards Valve 78
Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves 77
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) (October, qcac063, 2022) 77
Cardiac magnetic resonance for ischaemia and viability detection. Guiding patient selection to revascularization in coronary chronic total occlusions: The CARISMA_CTO study design 77
Acute Kidney Injury after Transcatheter Aortic Valve Implantation with Self-expanding CoreValve Prosthesis: Results From a Large Multicenter Italian Research Project 77
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 77
Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation 76
Assessing the Risk of Leaflet Motion Abnormality Following Transcatheter Aortic Valve Implantatio 76
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) 75
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 75
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves 73
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves 73
Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis 71
TAVR-Associated Prosthetic Valve Infective Endocarditis : Results of a Large, Multicenter Registry. 71
Real world safety and efficacy of transcatheter mitral valve repair with MitraClip. Thirty-day results from the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO) 71
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 70
Myocardial perfusion imaging after coronary artery bypass surgery using cardiovascular magnetic resonance: a validation study 69
Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry 69
How should I treat a coronary "traffic jam"? A triple kissing balloon in distal left main trifurcation 68
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 67
XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial 67
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 66
Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprostheses 65
Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction 65
Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves 64
Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation 64
Letter by Testa et al regarding article, "presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention" 64
Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves 64
Temporal Trends and Contemporary Outcomes after Transcatheter Aortic Valve Replacement with Evolut PRO/PRO+ Self-Expanding Valves: Insights from the NEOPRO/NEOPRO-2 Registries 63
Meta-Analysis of the Impact of Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Implantation 63
Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry 63
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 63
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 63
RENASCENT III First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results 62
Current concepts on antiplatelet therapy: focus on the novel thienopyridine and non-thienopyridine agents 62
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 62
The new era of oral anticoagulation: the 'finger pointing to the moon is not the moon'. Reply to: Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next? By Job Harenberg, Gregory Y.H. Lip 62
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 62
One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system 61
Emerging Technologies for Percutaneous Mitral Valve Repair 60
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition 60
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 60
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement 60
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 59
Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis 58
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study 58
SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice 58
Transcatheter Aortic Valve-in-Valve Implantation Using Lotus Valve for Failed Surgical Bioprostheses 58
Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis 57
Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting 57
Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients With Failing Bioprosthetic Aortic Valves: Mid-term Outcomes From the Italian CoreValve Clinical Service Project 57
Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis 57
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 57
Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis 57
Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging 56
Persistence of Severe Pulmonary Hypertension After Transcatheter Aortic Valve Replacement: Incidence and Prognostic Impact 56
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results 56
With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention 56
Infective Endocarditis Following Transcatheter Aortic Valve Replacement: Comparison of Balloon- Versus Self-Expandable Valves 56
Response to Letter by Prinzen et al Regarding Article "Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System" 56
Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Midterm Evaluation of Valve-in-Valve and Valve-in-Ring Implantation From the VIVID Registry 55
The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention 55
What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel 55
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 55
Role of imaging in interventions on structural heart disease 55
Transcatheter Treatment of Tricuspid and Mitral Regurgitation: Similar Path, Different Stages 55
Transcatheter mitral valve regurgitation treatment: State of the art and a glimpse to the future 55
Selection of Medications to Prevent Stroke Among Individuals With Atrial Fibrillation : Update on Prevention of Stroke in Patients with AF 54
Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results from the Global Valve-in-Valve Registry 54
Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery 54
Epidemiology of stroke and cerebral protection in patients undergoing transcatheter aortic valve replacement 54
Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease 53
Early Diagnosis of Perioperative Myocardial Infarction After Coronary Bypass Grafting: A Study Using Biomarkers and Cardiac Magnetic Resonance Imaging. 53
Totale 7.286
Categoria #
all - tutte 55.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 2 0 4 9 0 3 1 0 4
2022/2023122 38 21 11 3 8 15 3 5 2 0 2 14
2023/202470 18 3 6 3 0 6 0 5 3 2 5 19
2024/20251.730 53 20 5 158 60 167 359 183 221 221 145 138
2025/20266.820 561 425 460 787 483 564 560 392 1.957 337 130 164
2026/20272.141 202 529 470 940 0 0 0 0 0 0 0 0
Totale 10.916